PRAISE

Sleep Apnea

Obstructive Sleep Apnea (OSA) is a condition where breathing repeatedly stops during sleep, often without the indivi

It is estimated that up to 90% of individuals with OSA remain undiagnosed, despite associated risks including:

  • High blood pressure
  • Cardiovascular complications
  • Oxygen instability during sleep

Even when diagnosed, treatment adherence remains a challenge, often due to:

  • Low awareness or understanding of the condition
  • Lack of motivation or readiness to engage in treatment
  • Individual barriers such as limited support or low health literacy

The challenge is not just diagnosis – it is sustained engagement and behavior change.

What is PRAISE?

PRAISE is a personalized digital engagement program designed to improve treatment adherence for adults with Obstructive Sleep Apnea.

The program uses a behavioral science-driven approach, tailoring content based on each participant’s readiness for change and individual barriers to adherence.

Participants are assessed and grouped into stages of change:

  • Precontemplation
  • Contemplation
  • Preparation
  • Action
  • Maintenance

In addition, PRAISE identifies key barrier areas, including:

  • Social support
  • Intrinsic motivation
  • Sleep health literacy
  • Self-efficacy

Based on these inputs, participants receive:

  • Personalized SMS-based coaching messages (up to 10 per week)
  • Targeted educational video content aligned to their stage of change
  • Goal-setting and progress support
  • Access to a companion resource website

PRAISE delivers structured, adaptive support to help individuals move from awareness to sustained behavior change.

Pre-Contemplation

Contemplation

Preparation/Action

Outcomes

PRAISE is designed to:

  • Improve treatment adherence through personalized engagement
    • Messaging is tailored to individual readiness and barriers, supporting sustained behavior change
  • Increase patient awareness and understanding of sleep apnea
    • Educational content addresses knowledge gaps and reinforces key concepts over time
  • Support progression through stages of change
    • Structured interventions guide participants from early awareness to active treatment and maintenance
  • Address individual barriers to adherence
    • Targeted messaging focuses on motivation, literacy, self-efficacy, and support systems
  • Enable ongoing engagement through multi-channel support
    • SMS messaging combined with digital resources provides continuous, accessible guidance

The Team

PRAISE was developed in collaboration with:

  • Dr. Azizi Seixas
    • Director, Media and Innovation Laboratory (MIL), University of Miami Miller School of Medicine
    • Biomedical researcher and health-tech innovator focused on health behaviors, technology, and lifestyle
  • Dr. Girardin Jean-Louis
    • Professor of Population Health and Psychiatry, NYU Langone Health
    • Director, PRIDE Institute (NHLBI-funded), focused on addressing barriers to health behavior adoption

Interested?

Message us to get a demo or to learn more about the program.

Kellelo Health

The Problem: Challenges in Measurement-Based Mental Health Care Mental health care often lacks scalable, structured tools for ongoing measurement, patient engagement, and data-driven treatment decisions. Clinicians and organizations face challenges in: The challenge is improving visibility into patient progress while supporting more efficient and informed clinical decision-making. What is Kellelo

Learn more

SOFIA

SOFIA was created and validated in collaboration with Massachusetts General Hospital for children with ADHD to deliver reminders and educational messages to improve pediatric adherence and management of ADHD.

Learn more

Ring of Support

Allow seniors to age comfortably in their homes with an automated Interactive Voice Response and Smart Assistant virtual check-in.

Learn more

Keeping In Touch

KIT is a text message-based chatbot tool to provide educational and care navigation support for young adults with Type 1 Diabetes (T1D). KIT is currently being trialed by The Hospital for Sick Children (SickKids) and the McGill University Health Centre at four sites in Ontario and two sites in Quebec.

Learn more